home / stock / atrs / atrs quote
Last: | $5.59 |
---|---|
Change Percent: | 0.0% |
Open: | $0 |
Close: | $5.59 |
High: | $0 |
Low: | $0 |
Volume: | 3,890 |
Last Trade Date Time: | 12/31/1969 07:00:00 pm |
Quotes are delayed by 15 to 20 minutes.
Last | Open | Close | High | Low | Volume | Date |
---|---|---|---|---|---|---|
$5.59 | $0 | $5.59 | $0 | $0 | 3,890 | 09-08-2022 |
$5.59 | $0 | $5.59 | $0 | $0 | 6 | 09-07-2022 |
$5.59 | $0 | $5.59 | $0 | $0 | 612 | 08-26-2022 |
$5.59 | $0 | $5.59 | $0 | $0 | 1,304 | 08-25-2022 |
$5.59 | $0 | $5.59 | $0 | $0 | 4,776 | 08-09-2022 |
$5.59 | $0 | $5.59 | $0 | $0 | 1,800 | 08-05-2022 |
$5.59 | $0 | $5.59 | $0 | $0 | 2,436 | 08-04-2022 |
$5.59 | $0 | $5.59 | $0 | $0 | 1,082 | 08-03-2022 |
$5.59 | $0 | $5.59 | $0 | $0 | 14 | 07-29-2022 |
$5.59 | $5.58 | $5.59 | $5.6 | $5.58 | 2,703,913 | 05-23-2022 |
$5.59 | $5.585 | $5.59 | $5.59 | $5.58 | 1,763,397 | 05-20-2022 |
$5.58 | $5.58 | $5.58 | $5.59 | $5.58 | 2,602,120 | 05-19-2022 |
$5.58 | $5.57 | $5.58 | $5.58 | $5.57 | 1,346,970 | 05-18-2022 |
$5.58 | $5.58 | $5.58 | $5.58 | $5.57 | 1,412,639 | 05-17-2022 |
$5.57 | $5.575 | $5.57 | $5.58 | $5.57 | 1,594,921 | 05-16-2022 |
$5.57 | $5.56 | $5.57 | $5.58 | $5.56 | 1,829,525 | 05-13-2022 |
$5.57 | $5.57 | $5.57 | $5.58 | $5.54 | 7,110,900 | 05-12-2022 |
$5.56 | $5.56 | $5.56 | $5.57 | $5.56 | 3,333,808 | 05-11-2022 |
$5.56 | $5.57 | $5.56 | $5.57 | $5.55 | 3,244,656 | 05-10-2022 |
$5.56 | $5.56 | $5.56 | $5.57 | $5.56 | 2,632,734 | 05-09-2022 |
News, Short Squeeze, Breakout and More Instantly...
Antares Pharma Inc. Company Name:
ATRS Stock Symbol:
NASDAQ Market:
0.0% G/L:
$5.59 Last:
3,890 Volume:
$0 Open:
$5.59 Close:
Antares Pharma Inc. Website:
Hart-Scott-Rodino Waiting Period Expires for Halozyme's Acquisition of Antares Pharma PR Newswire SAN DIEGO , May 12, 2022 /PRNewswire/ -- Halozyme Therapeutics, Inc. (NASDAQ: HALO) (" Halozyme ") today announced that the waiting period unde...
Antares Pharma Inc shares ( NASDAQ: ATRS ) are up 45% on Wednesday after Halozyme Therapeutics said it will buy the New Jersey-headquartered company for $960 million in cash. Details of the agreement The deal translates to $5.60 per share for Antares Pharma shareholders that...